Trial Profile

A phase I study of ADI-001 in patients with Systemic-scleroderma

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 05 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ADI-001 (Primary)
Indications Systemic scleroderma
Focus Adverse reactions

Most Recent Events

27 Feb 2025 According to an Adicet media release, Patient enrollment is expected to be initiated in the second quarter of 2025.
06 Nov 2024 According to an Adicet media release,expects to initiate enrollment for patients in 1Q25.
19 Sep 2024 According to an Adicet media release, initial clinical data expected in the first half of 2025.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com